References
- Drug Facts and Comparisons, B. R. Olin, S. K. Hebel. Wolters Kluwer Co., St Louis 1995; 1614–1619, Facts and Comparisons, ed 49
- Garofalo E., Koto E., Feuerstein T., Goedecke A. G. Experience with gabapentin overdose: Five case studies (abstract). Epilepsia 1993; 34(Suppl 2)157
- Fischer J. H., Barr A. N., Rogers S. L., Fischer P. A., Trudeau V. L. Lack of serious toxicity following gabapentin overdose. Neurology 1994; 44: 982–983
- Satzinger G. Antiepilepticsfrom gamma-aminobutyric acid. Arzneirnittelforschung 1994; 44: 261–266
- Hill D. R. Suman-Chauhan N, Wooodruff GN. Localization of ‘3H’ gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol 1993; 244: 303–309
- Taylor C. P. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994; 44(Suppl 5)S10–S16
- Radulovic L. L., Wilder B. J., Leppik I. E., et al. Lack of interaction of gabapentin with carbamazepine or valproate. Epilepsia 1994; 35: 155–161
- Bockbrader H. N., Radulovic L. L., Loewen G., et al. Lack of drug-drug interaction between Neurontin (gabapentin) and other antiepileptic drugs (abstract). Epilepsia 1993; 34(Suppl 2)158
- MacDonald R. L., Kelly K. M. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 1994; 35(Suppl 4)S41–S50
- Honmou O., Kocsis J., Richerson G. B. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons. in vitro. Epilepsy Res 1995; 20: 193–202
- McLean M. Clinical pharmacokinetics of gabapentin. Neurology 1994; 44(Suppl 5)S17–S22
- Stewart B. H., Kugler A. R., Thompson P. R., Bockbrader H. N. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 1993; 10: 276–281
- UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990; 335: 1114–1117
- The US Gabapentin Study Group No.5. Gabapentin as add-on therapy in refractory epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993; 43: 2292–2298
- Anhut H., Ashman P., Feuerstein T. J., Sauermann W., Saunders M., Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994; 357: 795–801